SINOVAC BIOTECH LTD statistics & valuation
Profitability & efficiency
Gross margin (%)Operating margin (%)Return on equity (%)Shares outstandingNet debt ($)Share buybacks ($)Return on assets (%)Free cash flow margin (%)Debt / equity (×)EPS ($) Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|
| Gross margin | 67.9% | 61.1% | 68.8% | 55.3% | 94.9% | 86.8% | 86.8% | 89.2% | 88.4% | 69.1% |
| Operating margin | -127.0% | -139.9% | -151.9% | -34.5% | 91.0% | 42.2% | 27.9% | 19.7% | 26.0% | 0.7% |
| Net margin | — | — | -2.9% | 1.0% | 41.9% | 21.6% | 18.3% | 9.5% | 14.8% | -0.8% |
| FCF margin | -145.4% | -42.3% | -3.7% | -75.5% | 76.1% | 68.9% | 11.6% | 1.0% | 27.4% | -36.7% |
| Return on assets | — | — | -0.1% | 0.1% | 48.5% | 5.8% | 9.9% | 5.9% | 8.6% | -0.3% |
| Return on equity | — | — | -0.1% | 0.1% | 59.9% | 9.8% | 12.8% | 7.5% | 14.6% | -0.5% |
| Debt / equity | 0.08× | 0.04× | 0.02× | 0.00× | 0.00× | 0.03× | 0.02× | 0.02× | 0.19× | 0.31× |
| Current ratio | 4.59 | 7.33 | 8.97 | 9.00 | 5.93 | 2.30 | 4.01 | 4.88 | 2.20 | 1.97 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.
Stocktoria
